Conversely, HIF-2α has emerged as an oncogene that is essential for ccRCC tumor progression (Meléndez-Rodríguez et al., 2018; Schödel et al., 2016). The gene discussed is EPAS1; the disease is nonpapillary renal cell carcinoma.